Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Medtronic plc    MDT   IE00BTN1Y115

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic : Raises 2020 Guidance, Sets 4Q Outlook

share with twitter share with LinkedIn share with facebook
share via e-mail
02/18/2020 | 07:25am EDT

By Dave Sebastian

 

Medtronic PLC on Tuesday raised its fiscal 2020 adjusted-earnings guidance and set its outlook for the fourth quarter, which it expects the coronavirus outbreak to weigh on but can't yet quantify the effect.

Excluding the effect of the coronavirus outbreak, the medical-device company expects adjusted earnings of $5.63 a share to $5.65 a share, compared with its prior outlook of $5.57 a share to $5.63 a share. The outlook includes a seven-cent foreign-exchange effect, the company said.

Medtronic shares fell 0.8% in premarket trading after it reported higher third-quarter results, though sales were lower than expected.

For the fourth quarter, Medtronic said it is "comfortable" with the Wall Street consensus of an organic-revenue growth of about 4.5% and earnings of $1.64 a share, excluding the outbreak's effect. It expects fourth-quarter revenue growth to be hurt 0.8% to 1.4% if current exchange rates hold.

For the fourth quarter, analysts polled by FactSet expect earnings of $1.33 a share, or $1.64 a share on an adjusted basis. They see fourth-quarter revenue of $8.5 billion.

Analysts expect full-year earnings of $4.13 a share, or $5.60 a share on an adjusted basis, on revenue of $31.51 billion.

Write to Dave Sebastian at dave.sebastian@wsj.com

 

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on MEDTRONIC PLC
04/01MEDTRONIC : Makes Plans for a Ventilator Open-Source
AQ
03/30Medtronic Onyx ONE Clear Study of One-Month Dual-Antiplatelet Therapy in High..
GL
03/30MEDTRONIC : Publishes Design Specs for Ventilator to Combat Coronavirus
DJ
03/30MEDTRONIC : Shares Ventilation Design Specifications to Accelerate Efforts to In..
AQ
03/30MEDTRONIC : Launches New Solutions to Help Monitor Patients for COVID-19
AQ
03/30MEDTRONIC : Statement Regarding New York Times Article on March 29 2020
AQ
03/30MEDTRONIC : Receives FDA 'Breakthrough Device Designation' for Symplicity Spyral..
AQ
03/29MEDTRONIC : Landmark SPYRAL HTN-OFF MED Pivotal Trial Shows Superiority for Rena..
AQ
03/29Medtronic Evolut TAVR System Demonstrates Excellent Outcomes in Study of Low-..
GL
03/27Medtronic Launches New Solutions to Help Monitor Patients for COVID-19
GL
More news
Financials (USD)
Sales 2020 31 037 M
EBIT 2020 9 025 M
Net income 2020 5 807 M
Debt 2020 19 453 M
Yield 2020 2,48%
P/E ratio 2020 20,0x
P/E ratio 2021 18,7x
EV / Sales2020 4,35x
EV / Sales2021 4,17x
Capitalization 115 B
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Average target price 119,78  $
Last Close Price 86,15  $
Spread / Highest target 57,9%
Spread / Average Target 39,0%
Spread / Lowest Target 3,31%
EPS Revisions
Managers
NameTitle
Omar S. Ishrak Chairman & Chief Executive Officer
Geoffrey Straub Martha President & Director
Robert J. W. ten Hoedt President & EVP-Europe, Middle East & Africa
Mark Ploof Senior VP-Global Operations & Business Services
Karen L. Parkhill Chief Financial & Accounting Officer, Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC-23.96%120 856
BAXTER INTERNATIONAL INC.-1.67%41 180
HOYA CORPORATION-5.74%32 156
TERUMO CORPORATION-3.23%25 993
DEXCOM, INC.21.78%24 664
ZIMMER BIOMET HOLDINGS-38.06%20 891